MTOR and tuberous sclerosis: Several studies showed that the mammalian target of rapamycin (mTOR) serves a critical role in regulating the translational machinery that affects growth, proliferation, and differentiation, all of which are abnormally manifested in TSC lesions [18,19], which are associated with accumulation of fibrous proteins.